Bliss GVS Pharma Ltd. Financials

15:59 May 30

Bliss GVS Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
130.95
-2.60 (-1.95%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Bliss GVS Pharma Ltd. Financials

Bliss GVS Pharma Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
130.95
-2.60 (-1.95%)
15:59 May 30
Quality
image/svg+xml

62/100
High Financial Strength

Valuation
image/svg+xml

62/100
Affordable Valuation

Technical

48/100
Technically Neutral

Strength

8

Weakness

4

Opportunity

0

Threats

0

8.02 %

ROE %

6.48 %

ROA %

8.00

EPS

99.68

BVPS

10.41 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
577.21 747.45 751.59 770.24 809.73
Operating Expenses +
470.56 629.12 634.27 619.62 683.04
Raw Material
340.79 420.18 374.38 390.47 421.79
Increase Decrease in Cost
-11.88 -29.2 26.94 -8.35 -8.11
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
68.09 76.15 86.17 95.58 112.05
Miscellaneous Expenses
235.52 231.81 235.46 244.62 255.87
Operating Profit
106.65 118.33 117.32 150.62 126.69
Other Income
20.22 31.49 17.79 28.74 36.49
Depreciation
17.23 17.33 18.67 26.38 29.42
Interest
5.51 4.74 10.36 6.91 8.12
Profit before tax and exceptio..
104.13 127.76 106.07 146.07 125.64
Exceptional Items
0 -73.59 0 -29.2 0
PBT
104.13 54.17 106.07 116.87 125.64
Provision for Taxation
30.16 31.04 29.34 35.29 35.38
Net Profit
73.97 23.13 76.73 81.58 90.26
NET Profit after MI
68.49 15.04 70.86 75.45 84.3
EPS
6.64 1.46 6.72 7.23 7.95
Operating Profit Margin (%)
18.48 15.83 15.61 19.55 15.65
Net Profit Margin (%)
11.87 2.01 9.43 9.8 10.41

Bliss GVS Pharma Ltd. Shareholding

All Data in Percentage (%)

Mar 25 Dec 24 Sep 24 Jun 24 Mar 24
Promoter 35.30 35.10 34.80 34.90 35.00
FII 13.20 13.50 12.10 13.20 14.70
MF 0.00 0.00 0.00 0.00 0.00
Public 45.00 44.80 46.50 45.30 43.70
Others 0.00 0.00 0.00 0.00 0.00
Others 6.50 6.60 6.60 6.60 6.60
Shareholder Shares Holding %
Download Our App On: